[1]
Matsukawa, J. et al. 2025. Magnetic Resonance Imaging-Based Prediction of Uterine Fibroid Size Reduction by Relugolix Using T2-Weighted Signal Intensity Ratio: A Retrospective Multicenter Study. Journal of Clinical Gynecology & Obstetrics. 14, 2 (Jul. 2025), 52–58. DOI:https://doi.org/10.14740/jcgo1506.